SBIR Phase I: Use of Dynamic Electric Field Gradients for the Crystallization of Proteins

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0740491
Agency Tracking Number: 0740491
Amount: $99,691.00
Phase: Phase I
Program: SBIR
Awards Year: 2008
Solicitation Year: N/A
Solicitation Topic Code: BT
Solicitation Number: NSF 07-551
Small Business Information
1026 Roy J. Carver, Ames, IA, 50011
DUNS: 617265843
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Tonu Reinot
 PhD
 (515) 294-9046
 tonu@iastate.edu
Business Contact
 Tonu Reinot
Title: PhD
Phone: (515) 294-9046
Email: tonu@iastate.edu
Research Institution
N/A
Abstract
This Small Business Innovation Research Phase I project is for the development of technology to crystallize proteins using less sample and with higher speed and success than current high throughput protein crystallization methods. Protein crystallization is an intermediate step in determining the precise three-dimensional shape of a protein, and proteins are involved in virtually every cellular process. Precise knowledge of the three-dimensional shapes of proteins is very useful in a wide variety of applications, especially in predicting which drug candidates (each with a known shape) can bind to and potentially alter a particular protein?s function. It would also allow specific design of drugs to bind to sites identified on a target protein, thus increasing the potential for regulation of that protein. The broader impacts of this research will be a drastic reduction in the amount of time, money, and human effort necessary to develop new drugs thereby improving general overall health and reducing the cost of healtcare. Since many diseases are caused by perturbations in the function of one or more proteins in a cellular pathway, a method for quick and inexpensive analysis of protein structure would have far-reaching benefits to patients worldwide. Improvements in structural data acquisition will streamline basic proteomics research and revolutionize the process of drug discovery and development through enhanced scientific and technological understanding of underlying processes. The commercial value of this project arises from substantial conservation of manpower and funding, and will allow large pharmaceutical companies, as well as smaller biotechnology companies and academic scientists, to extend and enhance their research programs.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government